Gastroenterology and Liver

Alcoholic Liver Disease Studies

Alcoholic liver disease (ALD) remains a major cause of liver-related morbidity and mortality worldwide. This session will focus on pathophysiology, early detection, and comprehensive management strategies for ALD, including alcoholic hepatitis, steatosis, and cirrhosis. Participants will review advancements in non-invasive diagnostics, imaging, and biomarker-based approaches to assess disease severity and progression. Therapeutic interventions, including pharmacologic treatments, nutritional support, and behavioral therapy, will be presented to improve patient outcomes and reduce complications.

The track also explores multidisciplinary care models, integrating hepatologists, addiction specialists, dietitians, and psychologists to optimize treatment. Novel research in molecular mechanisms, targeted therapies, and regenerative approaches will be discussed to identify potential future interventions. Participants will gain insights into clinical challenges, emerging trends, and strategies for patient engagement, early intervention, and prevention, making this session a comprehensive resource for ALD research and care.